Growth Metrics

Eledon Pharmaceuticals (ELDN) Net Cash Flow Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 198.34%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 467.41%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -14,223.53%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 453.08%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -125.22%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 53.46%
10 Eledon Pharmaceuticals 419.90 Mn 203.87 Mn - -38.19%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -38.19%
Dec 31, 2025 38.71%
Sep 30, 2025 89.26%
Jun 30, 2025 -113.52%
Mar 31, 2025 -1,255.61%
Dec 31, 2024 1,360.11%
Sep 30, 2024 48.26%
Jun 30, 2024 347.95%
Mar 31, 2024 110.51%
Dec 31, 2023 109.97%
Sep 30, 2023 -715.58%
Jun 30, 2023 -32.23%
Mar 31, 2023 -21.68%
Dec 31, 2022 -2.95%
Sep 30, 2022 35.55%
Jun 30, 2022 16.51%
Mar 31, 2022 -45.23%
Dec 31, 2021 -3,323.05%
Sep 30, 2021 -107.49%
Jun 30, 2021 -146.47%
Mar 31, 2021 -287.58%
Dec 31, 2020 86.70%
Sep 30, 2020 3,376.74%
Jun 30, 2020 -165.01%
Mar 31, 2020 176.46%
Dec 31, 2019 39.65%
Sep 30, 2019 -0.84%
Jun 30, 2019 239.38%
Mar 31, 2019 -175.02%
Dec 31, 2018 -80.12%
Sep 30, 2018 16.15%
Jun 30, 2018 -118.92%
Mar 31, 2018 35.83%
Dec 31, 2017 -46.65%
Sep 30, 2017 -342.00%
Jun 30, 2017 132.31%
Mar 31, 2017 139.54%
Dec 31, 2016 86.12%
Sep 30, 2016 105.45%
Jun 30, 2016 121.62%
Mar 31, 2016 12.39%
Dec 31, 2015 -4,296.63%
Sep 30, 2015 -130.74%
Jun 30, 2015 -498.19%
Mar 31, 2015 -134.10%
Dec 31, 2014 -102.41%